SCIENTIFIC COMMITTEE
The Scientific Committee is responsible for reviewing proposals for research and related activities according to guidelines developed by the Board and making recommendations to the Board, and presenting the Board with annual reports and plans concerning the Society’s research activities. This Committee also reviews the applications submitted through the Histiocytosis Association's annual research funding program. The current members are:
Julien Haroche - Chair
Groupe Hospitalier Pitie-Salpetriere - Boulogne, France
Term of Office: 2019 - 2021
Rikhia Chakraborty
Texas Children's Cancer and Hematology Centers - Houston, TX USA
Term of Office: 2020 - 2022
Benjamin Durham
Memorial Sloan Kettering Cancer Center - New York, NY USA
Term of Office: 2019 - 2021
Jean-Francois Emile
Versailles University, Paris-Saclay University - Paris, France
Term of Office: 2019 - 2021
Michelle Hermiston
University of California, San Francisco - San Francisco, CA USA
Term of Office: 2019 - 2021
Caroline Hutter
Children's Cancer Research Institute - Vienna, Austria
Term of Office: 2019 - 2021
Paul Milne
Newcastle University - Newcastle, United Kingdom
Term of Office: 2020 - 2022
Jennifer Picarsic
Children's Hospital of Pittsburgh of UPMC - Pittsburgh, PA USA
Term of Office: 2019 - 2021
Yongmin Tang
Children's Hospital of Zhejiang University - Hangzhou, China
Term of Office: 2020 - 2022
Astrid van Halteren
Willem Alexander Children's Hospital / Leiden University Medical Center - Leiden, Netherlands
Term of Office: 2020 - 2022